A Clinical Phase I, Open-label, PET Study With [89Zr]-Df-CriPec® Docetaxel in Patients With Solid Tumours to Assess Biodistribution and Tumour Accumulation of [89Zr]-Df-CriPec® Docetaxel
Latest Information Update: 02 Sep 2022
At a glance
- Drugs Docetaxel (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 22 May 2022 According to Cristal Therapeutics media release, data from this trial was published in the peer-reviewed journal, Advanced Materials.
- 06 Oct 2020 Status changed from recruiting to completed.
- 04 Jun 2019 Results presented at the 55th Annual Meeting of the American Society of Clinical Oncology.